Related Experiment Video
Updated: Oct 2, 2026

Application of DNA Fingerprinting using the D1S80 Locus in Lab Classes
Published on: July 17, 2021
Italian familial defective apolipoprotein B patients share a unique haplotype with other Caucasian patients
A B Cefalù1, C M Barbagallo, E Sesti
1Istituto di Medicina Interna e Geriatria, Department of Internal Medicine, University of Palermo, Policlinico Paolo Giaccone, Italy.
Insights
Familial defective apolipoprotein B-100, a genetic cause of high cholesterol, was studied in Italy. The Arg3500Gln mutation prevalence was low, associated with a specific gene haplotype.
Area of Science:
- Genetics
- Biochemistry
- Cardiovascular Medicine
Background:
- Familial hypercholesterolemia is a common genetic disorder characterized by high cholesterol levels.
- Familial defective apolipoprotein B-100 (apo B-100) is a significant genetic cause of hypercholesterolemia.
- Specific mutations in the apo B gene, particularly around codon 3500, lead to defective apo B-100.
Purpose of the Study:
- To investigate the prevalence of familial defective apo B-100, specifically the Arg3500Gln mutation, in Italian populations.
- To identify and characterize new cases of familial defective apo B-100 in Italy.
- To analyze the apo B gene haplotype co-segregating with the Arg3500Gln mutation in Italian families.
Main Methods:
- Screening of probands diagnosed with Familial Hypercholesterolemia from mainland Italy and Sicily.
- Genetic analysis to identify specific mutations (Arg3500Gln, Arg3531Cys) in the apo B gene.
- Haplotype analysis of the apo B gene in affected families.
Main Results:
- Three new Italian families with the Apo B Arg3500Gln mutation were identified (one from Liguria, two from Sicily).
- The prevalence of the Apo B Arg3500Gln mutation was found to be low (0.28% in mainland Italy, 0.65% in Sicily).
- The Apo B Arg3531Cys mutation was not detected in any of the screened individuals.
- The Arg3500Gln mutation consistently co-segregated with a specific apo B haplotype in Italian families, consistent with previous findings in Caucasian populations.
Conclusions:
- Familial defective apo B-100 due to the Arg3500Gln mutation is present but rare in the studied Italian populations.
- The identified apo B haplotype provides a genetic marker for this mutation in Italy.
- Further research may be warranted to understand the geographical distribution and clinical impact of this mutation in diverse populations.
Abstract:
Familial defective apolipoprotein (apo) B-100 together with familial hypercholesterolemia are the two common genetic conditions that cause hypercholesterolemia. Familial defective apolipoprotein B-100 is due to mutations around codon 3500 of the apo B gene. The most-characterized mutation is a G>A transition at nucleotide 10,708 that results in the substitution of arginine by glutamine at codon 3500 (Apo B Arg3500Gln). Two other mutations are caused by a C>T transition, one at nucleotide 10,800 (Apo B Arg3531Cys) and the other at nucleotide 10,707 (apo B Arg3500Trp). In the present study we describe three new Italian cases of familial defective apolipoprotein B-100 (Apo B Arg3500Gln), one from the Liguria region and two from Sicily, and the haplotype of the apo B gene co-segregating with the mutation. By screening two groups of probands, clinically diagnosed as having Familial Hypercholesterolemia (700 from mainland Italy and 305 from Sicily), the prevalence of familial defective apolipoprotein B-100 due to Arg3500Gln was found to be very low (0.28% and 0.65%, respectively). The Arg3531Cys mutation was not detected in any proband. In the three new families with Arg3500Gln mutation in the present study and in one previously described in Italy, the mutation was associated with a unique apo B haplotype, which is consistent with data previously reported for Caucasian patients [XbaI-, MspI+, EcoRI-, presence of the 5' signal peptide insertion (Ins) allele, and the 49-repeat allele of the 3'-VNTR].
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
Related Concept Videos
Pedigree Analysis
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Pharmacogenomics: Identification of New Drug Targets
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Genetic Lingo
Pleiotropy